✦ LIBER ✦

Treatment of renal transplantation in brazil after the loss of tacrolimus patent: A cost-effectiveness analysis

✍ Scribed by Saturnino, L.T.M.; Silva, A.L.; Acurcio, F.D.A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TPRD4: THE COST-EFFECTIVENESS OF IMMUNOS

✍ T Clark; YCT Shih; B Dupuis; A Hartzema 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

PUK13 COST-EFFECTIVENESS ANALYSIS OF THE

✍ O. Gamboa; C. Montero; L. Mesa; C. Benavides; A. Reino; J.S. Castillo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Coadministration of tacrolimus and ketoc

✍ L Soltero; H Carbajal; C Rodríguez-Montalvo; A Valdés 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Cost-effectiveness analysis of timely di

✍ Guillermo Villa, Emilio Sánchez-Álvarez, Jesús Cuervo, Lucía Fernández-Ortiz, Pa 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 315 KB

The cost-effectiveness of prophylaxis wi

✍ Christophe Legendre; Stephen M. Beard; Anne Crochard; Yvon Lebranchu; Claire Pou 📂 Article 📅 2005 🏛 Springer 🌐 French ⚖ 188 KB

Cost-Effectiveness of Pazopanib as First

✍ Pepe, C.; Sedlmayer, C.; Machado, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB